BAGGING CASH: Sales of Pfizer coronavirus vaccine and treatment pushed the drugmaker past expectations in the first quarter as profit grew 61 percent.
Global sales of Pfizer’s coronavirus vaccine and treatment drove the drug maker into new territory in the first quarter of 2022 as profit grew 61 percent on the back of a 77 percent overall revenue leap.
The New York-based Pfizer Inc. reported Tuesday the coronavirus vaccine Comirnaty delivered more than $13 billion in sales while the treatment Paxlovid added another $1.5 billion as company revenue swelled 77 percent.Pfizer also revised its 2022 earnings forecast to reflect an accounting policy change. It now expects adjusted earnings of $6.25 to $6.45 per share.
Producers of the Pfizer vaccine, BioNTech, last year stood amongst the first manufacturers to push for clearance to vaccinate children five and older as the company announced it was ready to begin making smaller doses for children younger than 12. Producers of the Pfizer vaccine, BioNTech, are preparing to request clearance to vaccinate children five years old and older.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Lire la suite »
Pfizer Sales Soar on Covid-19 Vaccine SalesPfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Lire la suite »
Pfizer beats Q1 estimates as COVID vaccine and antiviral boost revenuePfizer Inc. undefined posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The...
Lire la suite »
Pfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June
Lire la suite »
Pfizer hopes to submit little-kid vaccine data by early JunePfizer now hopes to tell U.S. regulators how well its COVID-19 vaccine works in the littlest kids by early June.
Lire la suite »
Tesla's Unconventional Sales Model Could Mark the End of Traditional Car Dealershipswith shifts to electric vehicles,the auto industry is also beginning to witness the decline of the decades-old dealership model
Lire la suite »